Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pandemic's toll on cancer patients with neuropathy under the microscope

NCT ID NCT04650178

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 33 times

Summary

This study looks at how the COVID-19 pandemic impacted the quality of life of 274 cancer patients who also have neuropathy (nerve pain). All participants had taken part in earlier clinical trials. Researchers want to see if there are differences between those who received a brain-training therapy called neurofeedback and those who did not. The goal is to learn how to better support patients during future health emergencies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help develop better programs and policies to support chronic pain patients during major health crises like a pandemic.

What could go wrong

This is an observational study, not a treatment trial, so it will not directly improve health. Results are based on questionnaires and may not apply to all patients.

Conditions

The condition(s) this trial relates to.

cancer COVID-19 hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.